Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
DCTH
DCTH
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
DCTH News
Delcath Systems to Host Q4 2025 Earnings Call on February 26, 2026
3d ago
Newsfilter
Delcath Systems Reports Preliminary 2025 Revenue of $85.2 Million
Jan 09 2026
Newsfilter
Three Microcap Companies Show Healthy Growth: OPXS, DCTH, MAMA
Jan 06 2026
Benzinga
Delcath's HEPZATO KIT Shows Consistent Tumor Responses, Q3 Revenue Hits $19.3 Million
Jan 02 2026
NASDAQ.COM
Delcath Publishes FOCUS Study Subgroup Analysis Results, Demonstrating Significant Efficacy
Dec 31 2025
Newsfilter
Delcath Publishes 10-Year Study on Liver Cancer Treatment with 29.1 Months Survival Rate
Dec 03 2025
Newsfilter
Are Options Traders Aware of Insights About Delcath Systems Stock That We Are Not?
Nov 24 2025
NASDAQ.COM
Biotech Stocks Fluctuate Post-Market: Delcath Gains from Buyback, BioVie and Cassava Recover
Nov 21 2025
NASDAQ.COM
Delcath Systems Reveals Release of Expert Review on Percutaneous Hepatic Perfusion for Uveal Melanoma Liver Metastases
Nov 18 2025
Newsfilter
Delcath Systems Inc. Reports Decline in Q3 Earnings, Exceeding Expectations
Nov 04 2025
NASDAQ.COM
Canaccord Genuity Reaffirms Buy Rating for Delcath Systems, Keeps $21 Price Target Intact
Oct 21 2025
Benzinga
Delcath Shares Fall 5% Following Preliminary Q3 Results and Revised Full-Year Forecast
Oct 20 2025
NASDAQ.COM
Delcath Systems announces $20.5M revenue for Q3 and revises FY revenue forecast downward.
Oct 20 2025
SeekingAlpha
Key Earnings Reports to Watch Before Monday's Market Open
Oct 19 2025
SeekingAlpha
Delcath Systems Reports Initial Financial Results for Third Quarter 2025
Oct 18 2025
Newsfilter
Delcath Systems Reports Successful Achievement of Primary Endpoint in Investigator-Initiated CHOPIN Clinical Trial
Oct 18 2025
Yahoo Finance
Show More News
